Company Filing History:
Years Active: 2019-2020
Title: Gundeep Dhillon: Innovator in Organ Transplantation
Introduction
Gundeep Dhillon is a notable inventor based in Stanford, CA, who has made significant contributions to the field of organ transplantation. With a focus on improving clinical outcomes for solid organ transplants, his work has the potential to enhance the quality of life for many patients.
Latest Patents
Gundeep Dhillon holds 2 patents, including his latest invention, the HIF-1 modulator paint formulation and its uses. This innovative formulation provides methods for improving the function of solid organ transplants, particularly lung transplantation. The invention involves a nanoparticle formulation that includes an effective dose of an iron chelator active agent, such as deferoxamine (DFO), deferasirox (DFX), and deferiprone (DFP). This formulation is suspended in a carrier compatible with the tissue of interest and is topically applied to the surface of tissues at the site of anastomosis. The nanoparticles consist of the active agent and a pharmaceutically acceptable stabilizer, showcasing a novel approach to enhancing transplant outcomes.
Career Highlights
Throughout his career, Gundeep Dhillon has worked with prestigious institutions, including Leland Stanford Junior University and The Johns Hopkins University. His experience in these renowned organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Gundeep has collaborated with esteemed colleagues such as Mark R. Nicolls and Jayakumar Rajadas, contributing to the advancement of research in organ transplantation.
Conclusion
Gundeep Dhillon's work in developing innovative solutions for organ transplantation exemplifies the impact of research and invention in improving patient care. His contributions are paving the way for future advancements in the field.